THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah.

Slides:



Advertisements
Similar presentations
Advances in the Management of BPH
Advertisements

HEALTH WISE FOR MEN Keep thy heart with all diligence, for out of it are the issues of life. Proverbs 4:23 (KJV) Bob White, AIM-IRS ABMTS Milwaukee, WI.
Current Opinion in Urological Cancer
Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA
Prostate cancer diagnosis today Mungai Ngugi. Introduction Prostate cancer remains a major problem in the world and particularly in black people who have.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
AM Report 9/11/09 Prostate Cancer Julia Rauch. Disease Burden ~220,000 men were diagnosed with prostate cancer in 2007 ~1/6 men will receive the disagnosis.
Prevention Strategies Rajesh G. Laungani MD Director, Robotic Urology Chairman, Prostate Cancer Center Saint Joseph’s Hospital, Atlanta.
High-grade Prostatic Intraepithelial Neoplasia on Needle Biopsy Risk of Cancer on Repeat Biopsy Related to Number of Involved Cores and Morphologic Pattern.
Role of MRI and MRSI in The Management of Prostate Cancer Karim Touijer, MD.
Prostate Needle Biopsy: The Pitfalls and the Role of the Pathologist – Patient Track Prostate Cancer Symposium “Intriguing Cases / Emerging Strategies.
PROSTATE CANCER LETS DEBATE !!!! Dr Fred C Tyler MBChB FRCS FCS UROL.
EVIDENCE AND DEBATE SCREENING FOR PROSTATE CANCER.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.
Medical Therapy of Prostate Symptoms (MTOPS) Jeannette Y. Lee, Ph.D. University of Alabama at Birmingham.
Eleni Galani Medical Oncologist
Professor Abhay Rane OBE
Should I have that blood test for Prostate Cancer?
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Neoplasms of the Prostate Gland
Pathology of Prostate Gland
Urology Update Sanofi- Aventis
Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
A GENERAL OVERVIEW OF PROSTATE CANCER. PROSTATE CANCER 101 SPONSORED BY THE CALIFORNIA STATE PROSTATE CANCER COALITION AND THE NATIONAL ALLIANCE OF STATE.
NYU Medical Grand Rounds Clinical Vignette Josie Ni, PGY-3 9/13/11 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
All about PSA (not Pharmaceutical Society of Australia)
Prostate Pathology Emad Raddaoui, MD, FCAP, FASC.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
男性生殖系统疾病 前列腺疾病 Prostate diseases Zhu keqing 竺可青 Pathology Department Zhejiang University School of Medicine
Men’s Health Prostate Awareness. Prostate Where is it? Where is it? What is a prostate? What is a prostate? What’s the issue? What’s the issue?
Poster Title ABSTRACT #59 Cell cycle progression genes differentiate indolent from aggressive prostate cancer. Steven Stone 1 Jack Cuzick 2, Julia Reid.
Prostate Pathology. Prostate weighs 20 grams in normal adult Retroperitoneal organ,encircling the neck of bladder and urethra Devoid of a distinct capsule.
Prostate Dr. Amitabha Basu MD.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
Anmar Nassir, Assistant Prof, Um Al-Qura Univ Hasan Farsi, Prof, KAUH Ammar Dehlawi, Teach assist Um Al-Qura Univ.
Emerge of Crohn’s Disease Incidence in Saudi Arabia; Tertiary Care Centre Experience NA Azzam, A Al-Jebreen, A Abdo, K AI- Suwat, IA Al-Mofleh, RS Al-Rashid,
Genitourinary Blueprint
Prostate Dr. Atif Ali Bashir MD. Prostate Pathology ► Prostate weighs 20 grams in normal adult ► Retroperitoneal organ,encircling the neck of bladder.
South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
PHYSIOTHERAPY OF PELVIC FLOOR FOR URINARY INCONTINENCE’S TREATMENT AFTER FREYER OR MILLIN OPEN TECHNIQUES OR TRANSURETHRAL PROSTATECTOMY Borrego-Jiménez.
Diseases of the prostate Osvaldo Rubinstein, MD. Normal urinary bladder with right and left ureters.
IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.
Boksoon Chang, MD ; Jung Hye Hwang, MD ; Yoon-Ho Choi, MD ; Man Pyo Chung, MD, PhD ; Hojoong Kim, MD, PhD, FCCP ; O Jung Kwon, MD, PhD ; Ho Yun Lee, MD.
Prostate Pathology Sufia Husain. Pathology Department KSU, Riyadh
Prostate Pathology Sufia Husain. Pathology Department KSU, Riyadh
International Neurourology Journal 2010;14:
Prostate Cancer Screening in the fit Chilean Elderly: a head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate.
Site(s) of Involvement Serum IgG4 Level (mg/dL) Treatment with Steroid
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Copyright © 1998 American Medical Association. All rights reserved.
Prostate Cancer Dr .Gehan Mohamed.
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
RELAZIONE TRA “STAGE MIGRATION” E
Prognosis of younger patients in non-small cell lung cancer
R. Lobetti1,2, E. Lindquist2, C.Berman1
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
Apollo Gleneagles Hospitals,
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Prostate Cancer Screening- Update
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Multigene Genomic Testing (ONCOTYPE DX)
Presentation transcript:

THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah A. Al-Maghrabi, MD, FRCPC* Wisam K. Kamal, MBBS Hisham A. Saadah, MD* Hasan M. A. Farsi, FRCSC, FACS

Introduction: Little is known about the clinico- pathological nature of prostatic diseases in Saudi men For example: we still need to better define our local predisposition factors and the criteria for prognostic risk stratification Objective of study: to identify the features of prostatic diseases which is the initial step for adequate planning of health care

Material and methods: 2 major referral hospitals in Jeddah ◦KAUH: recently renamed KAUMC ◦KFSH & RC June 2003 – June patients Age range yrs., median 68 Medical records were reviewed for ◦Presentation ◦Results of DRE ◦PSA ◦Indications for biopsy or surgery ◦Histo-pathological diagnosis ◦Tumor grading, Gleason scoring

Material and methods: All pathological slides were reviewed by one pathologist (JAM) specializing in GU cancers Benign disease: ◦BPH ◦Inflammation:  degree ◦ Acute, chronic ◦ Focal, diffuse ◦ Peri-glandular, glandular & stromal Cancer:  Type: adenocarcinoma, others  Gleason grading & score

DiagnosisNo./Total(%) Adenocarcinoma94/330(28.5%) BPH143/330(43.3%) BPH with Inflammation67/330(20.3%) Inflammation14/330(4.2%) Others: TCC infiltration (8) SCC infiltration (1) Leiomyomatous nodules (1) Non Hodgkin’s lymphoma (1) Extension from colonic cancer (1) 12/330(3.6%) Overall Distribution Of Different Prostatic Disorders In 330 Prostatic Specimens Results:

Results: Indication No./Total (%) Elevated PSA46/54 (85%) Abnormal DRE 3/54 (5.5%) Elevated PSA +Abnormal DRE 5/54 (9.3%) Indications for prostatic TRUS biopsy in 54 patients with Prostate Cancer

PSA values at Diagnosis among 66 patients with Prostate Cancer PSA (ng/ml) Range: No./Total (%) 4>4> 9/66 (13.6%) /66 (13.6%) /66 (19.7%) >2035/66 (53.0%) Results:

Grade (Gleason Sum)No./Total (%) Well Differentiated (4/10) Total 3/83 (3.6%) Moderately Differentiated (5/10) (6/10) (7/10) Total 3/83 (3.6%) 25/83 (30%) 23/83 (27.7%) 51/83 (61.4%) Poorly Differentiated (8/10) (9/10) (10/10) Total 18/83 (21.7%) 9/83 (11.0%) 2/83 (02.4%) 29/83 (35.0%) Histological Grading And Gleason Score of 83 Patients With Prostate Cancer Results:

Results: There was an incidental finding of adenocarinoma in 14 out of 93 of Open & transurethral prostatectomy specimens i.e. Stages Ta & Tb =15% PSA less than 4ng/ml in 13.6% of cancer pateints Gleason score: out of the 83 prostate cancer specimens: ◦≥6 in 77 i.e. 92.8% and ◦≥7 in 52 i.e. 62.8%

Discussion More than a decade ago, our center (KAUH) reported a 7.2% rate of incidental prostate cancer detected in surgical specimens removed from clinically presumed benign disease (stages T1a and T1b), compared with international rates of 10-20% at that time Mosli HA. Incidental Adenocarcinoma of the Prostate: Frequency Rate at a Tertiary Care Hospital. Annals of Saudi Medicine 1997; 17:

A Study on 535 prostate specimens at KAUH, Jeddah : ◦54(10%) Prostate Cancer ◦481(90%) Benign lesions:  440(82.2%):BPH, 145(33%) were associated with inflammatory reaction: ◦ 133(24.9%): Chronic prostatitis ◦ 17(3.1): Acute prostatitis ◦ 5(0.9%): Chronic granulomatous prostatitis, 4 cases were T.B. Mansoor I: Pattern of Prostatic Diseases in Saudi Arabia, Internet Journal of Pathology, 2003, Vol.2 No.2 Previous Studies-Saudi Arabia

A study on 505 prostate specimens ◦75(15%) were prostate cancer ◦234(46%) were BPH with no other disorder ◦196(39%) were BPH associated with inflammatory reaction Zabar K, Jalal A, Ebrahim M: Retrospective Analysis of Patients with lower Urinary Tract Symptoms due Benign Prostatic Hyperplasia, Bahrain Med. Bull, 28(4), 2006 Previous Studies- Bahrain

Previous Studies -Oman A study on 1163 patients underwent TURP and prostate biopsies ◦10.9% were diagnosed as having prostate cancer ◦Unfortunately, Prostatitis was not looked at as it was considered a clinical diagnosis George E., Thomas S.: A histo-pathological Survey of Prostate Disease in The Sultanate of Oman. The Internet Journal of Pathology 2005, vol.2, no.2

Conclusions: Although the incidence of prostate cancer is low in Saudi Arabia, it usually takes place as high grade disease Incidental prostate cancer detected in surgical specimens removed from clinically presumed benign disease is rising Our findings support the recommendations to lower the PSA cutoff value for prostatic biopsy to 2.5 rather than 4 ng/ml., otherwise we may miss a considerable number of our cancer patients

Thank you